Insulet said results from its study of a fully closed-loop automated insulin delivery system for type 2 diabetes shows an improvement over standard injection therapy. Insulet said its system showed 68 ...

Submission is to expand HYMPAVZI indication to the treatment of hemophilia A or B patients 6 years and older with inhibitors, and pediatric patients (ages 6 to 11) without inhibitors If approved, ...

Medtronic plans to launch the MiniMed Go app this spring. The company said the feature helps people using insulin pens with glycemic control. A retrospective analysis found the average time in range, ...

The ILUMYA Pen offers eligible patients a safe and effective treatment option that supports ease of use and may help reduce clinical visits through self-administration MUMBAI, India and BRAMPTON, ON, ...

As of January, California is the first state in the country to partner with a nonprofit to develop, produce and sell its own insulin as a solution to the widespread unaffordability of the life-saving ...

EXPECTING SOME FREEZING TEMPERATURES TO START ROLLING IN SCOTT. I FEEL LIKE THIS HAS TO BE THE BUZZ AT EVERY BREAK ROOM AT WORK THIS WEEK. HAVE YOU HEARD ABOUT THE COLD WEATHER THAT’S COMING? LOOK AT ...

December 8, 2025 – United States Attorney for the Southern District of New York, Jay Clayton, Special Agent in Charge of the New York Regional Office of the U.S. Department of Health and Human ...

Pharmacy chain CVS will pay $37.8 million for dispensing and billing health care plans including the military’s Tricare for more insulin than was prescribed for the pharmacy’s diabetic customers, ...

CVS Health (CVS) has reached a settlement with the U.S. government, requiring the company to pay $37.76M to resolve claims that it overbilled government healthcare programs for insulin pens. The ...

NEW YORK, Dec 2 (Reuters) - CVS Health (CVS.N), opens new tab will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients, and then obtained improper reimbursements ...

CVS Health agreed to pay $37.76 million to settle allegations that it dispensed too many insulin pens to patients and improperly billed federal healthcare programs for those insulin prescriptions. The ...